These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 7769713)
1. Sequences derived from the highly antigenic VP1 region 140 to 160 of foot-and-mouth disease virus do not prime for a bovine T-cell response against intact virus. van Lierop MJ; Wagenaar JP; van Noort JM; Hensen EJ J Virol; 1995 Jul; 69(7):4511-4. PubMed ID: 7769713 [TBL] [Abstract][Full Text] [Related]
2. Induction of anti foot and mouth disease virus T and B cell responses in cattle immunized with a peptide representing ten amino acids of VP1. Zamorano PI; Wigdorovitz A; Pérez Filgueira DM; Escribano JM; Sadir AM; Borca MV Vaccine; 1998 Apr; 16(6):558-63. PubMed ID: 9569465 [TBL] [Abstract][Full Text] [Related]
3. [Antigenic structure of the foot-and-mouth virus. VI. Functional segments of the immunodominant region of the VP1 protein of foot-and-mouth virus strains O1K and A22]. Gel'famov VM; Grechaninova LA; Kan ES; Iarov AV; Surovoĭ AIu; Vol'pina OM; Chepurkin AV; Ivanov VT Bioorg Khim; 1991 May; 17(5):596-605. PubMed ID: 1722673 [TBL] [Abstract][Full Text] [Related]
4. T cell-stimulatory fragments of foot-and-mouth disease virus released by mild treatment with cathepsin D. van Lierop MJ; van Noort JM; Wagenaar JP; Rutten VP; Langeveld J; Meloen RH; Hensen EJ J Gen Virol; 1994 Nov; 75 ( Pt 11)():2937-46. PubMed ID: 7964603 [TBL] [Abstract][Full Text] [Related]
6. A 10-amino-acid linear sequence of VP1 of foot and mouth disease virus containing B- and T-cell epitopes induces protection in mice. Zamorano P; Wigdorovitz A; Perez-Filgueira M; Carrillo C; Escribano JM; Sadir AM; Borca MV Virology; 1995 Oct; 212(2):614-21. PubMed ID: 7571431 [TBL] [Abstract][Full Text] [Related]
7. Recognition of foot-and-mouth disease virus and its capsid protein VP1 by bovine peripheral T lymphocytes. Garcia-Valcarcel M; Doel T; Collen T; Ryan M; Parkhouse RM J Gen Virol; 1996 Apr; 77 ( Pt 4)():727-35. PubMed ID: 8627261 [TBL] [Abstract][Full Text] [Related]
8. OmpA-FMDV VP1 fusion proteins: production, cell surface exposure and immune responses to the major antigenic domain of foot-and-mouth disease virus. Ruppert A; Arnold N; Hobom G Vaccine; 1994 May; 12(6):492-8. PubMed ID: 8036821 [TBL] [Abstract][Full Text] [Related]
9. Delineation of a neutralizing subregion within the immunodominant epitope (GH loop) of foot-and-mouth disease virus VP1 which does not contain the RGD motif. Brown F; Benkirane N; Limal D; Halimi H; Newman JF; Van Regenmortel MH; Briand JP; Muller S Vaccine; 1999 Aug; 18(1-2):50-6. PubMed ID: 10501234 [TBL] [Abstract][Full Text] [Related]
10. A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants. Taboga O; Tami C; Carrillo E; Núñez JI; Rodríguez A; Saíz JC; Blanco E; Valero ML; Roig X; Camarero JA; Andreu D; Mateu MG; Giralt E; Domingo E; Sobrino F; Palma EL J Virol; 1997 Apr; 71(4):2606-14. PubMed ID: 9060612 [TBL] [Abstract][Full Text] [Related]
11. Antigenic specificity of porcine T cell response against foot-and-mouth disease virus structural proteins: identification of T helper epitopes in VP1. Rodríguez A; Sáiz JC; Novella IS; Andreu D; Sobrino F Virology; 1994 Nov; 205(1):24-33. PubMed ID: 7526534 [TBL] [Abstract][Full Text] [Related]
12. Protection conferred by TrpE fusion proteins containing portions of the C-terminal region of capsid protein VP1 of foot-and-mouth disease virus. Giavedoni LD; Kaplan G; Marcovecchio F; Piccone ME; Palma EL J Gen Virol; 1991 Apr; 72 ( Pt 4)():967-71. PubMed ID: 1849980 [TBL] [Abstract][Full Text] [Related]
13. Bovine herpesvirus-1 (infectious bovine rhinotracheitis virus)-based viral vector which expresses foot-and-mouth disease epitopes. Kit M; Kit S; Little SP; Di Marchi RD; Gale C Vaccine; 1991 Aug; 9(8):564-72. PubMed ID: 1722936 [TBL] [Abstract][Full Text] [Related]
15. Association of bovine DRB3 alleles with immune response to FMDV peptides and protection against viral challenge. García-Briones MM; Russell GC; Oliver RA; Tami C; Taboga O; Carrillo E; Palma EL; Sobrino F; Glass EJ Vaccine; 2000 Dec; 19(9-10):1167-71. PubMed ID: 11137253 [TBL] [Abstract][Full Text] [Related]
16. A peptide construct containing B-cell and T-cell epitopes from the foot-and-mouth disease viral VP1 protein induces efficient antiviral protection. Volpina OM; Surovoy AY; Zhmak MN; Kuprianova MA; Koroev DO; Chepurkin AV; Toloknov AS; Ivanov VT Vaccine; 1999 Feb; 17(6):577-84. PubMed ID: 10075164 [TBL] [Abstract][Full Text] [Related]
17. Induction of effective cross-reactive immunity by FMDV peptides is critically dependent upon specific MHC-peptide-T cell interactions. Glass EJ; Millar P Immunology; 1994 May; 82(1):1-8. PubMed ID: 8045586 [TBL] [Abstract][Full Text] [Related]
18. Recognition of B and T cell epitopes by cattle immunized with a synthetic peptide containing the major immunogenic site of VP1 FMDV 01 Campos. Zamorano P; Wigdorovitz A; Chaher MT; Fernandez FM; Carrillo C; Marcovecchio FE; Sadir AM; Borca MV Virology; 1994 Jun; 201(2):383-7. PubMed ID: 8184548 [TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies, against O1 serotype foot-and-mouth disease virus, from a natural bovine host, recognize similar antigenic features to those defined by the mouse. Barnett PV; Samuel AR; Pullen L; Ansell D; Butcher RN; Parkhouse RM J Gen Virol; 1998 Jul; 79 ( Pt 7)():1687-97. PubMed ID: 9680132 [TBL] [Abstract][Full Text] [Related]
20. Protection against viral infections with the aid of synthetic peptides. Foot-and-mouth disease as an example. Vol'pina OM; Surovoi AYu ; Ivanov VT Biomed Sci; 1990 Jan; 1(1):23-32. PubMed ID: 1718462 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]